142 related articles for article (PubMed ID: 34030794)
21. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol Hepatol; 2018 Jan; 33(1):232-239. PubMed ID: 28440889
[TBL] [Abstract][Full Text] [Related]
22. EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome.
Zhang L; Wang R; Chen Y; Yang P; Bai T; Song J; Hou X
Life Sci; 2022 Apr; 295():120419. PubMed ID: 35183555
[TBL] [Abstract][Full Text] [Related]
23. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
[TBL] [Abstract][Full Text] [Related]
24. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
25. TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity.
Yuan B; Tang WH; Lu LJ; Zhou Y; Zhu HY; Zhou YL; Zhang HH; Hu CY; Xu GY
World J Gastroenterol; 2015 Jul; 21(28):8615-28. PubMed ID: 26229403
[TBL] [Abstract][Full Text] [Related]
26. NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.
King AJ; Chang L; Li Q; Liu L; Zhu Y; Pasricha PJ; Wang J; Siegel M; Caldwell JS; Edelstein S; Rosenbaum DP; Kozuka K
Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G543-G554. PubMed ID: 38252683
[TBL] [Abstract][Full Text] [Related]
27. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
Zhang JD; Liu J; Zhu SW; Fang Y; Wang B; Jia Q; Hao HF; Kao JY; He QH; Song LJ; Liu F; Zhu BL; Owyang C; Duan LP
Acta Pharmacol Sin; 2021 Nov; 42(11):1821-1833. PubMed ID: 33558654
[TBL] [Abstract][Full Text] [Related]
28. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
29. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
[TBL] [Abstract][Full Text] [Related]
31. Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells.
Sun Y; Liu X; Wang L; Li L; Quan X; Shi H; Wang T; Mei L; Chen Y; Zhang Y; Li J; Meng R; Wang J; Dai F
Eur J Pharmacol; 2023 May; 946():175650. PubMed ID: 36907262
[TBL] [Abstract][Full Text] [Related]
32. Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat model.
Yang JM; Xian YF; Ip PS; Wu JC; Lao L; Fong HH; Sung JJ; Berman B; Yeung JH; Che CT
Phytomedicine; 2012 Mar; 19(5):402-8. PubMed ID: 22230486
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats.
Zhang J; Song L; Wang Y; Liu C; Zhang L; Zhu S; Liu S; Duan L
J Gastroenterol Hepatol; 2019 Aug; 34(8):1368-1376. PubMed ID: 30402954
[TBL] [Abstract][Full Text] [Related]
34. Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity.
Liu HR; Fang XY; Wu HG; Wu LY; Li J; Weng ZJ; Guo XX; Li YG
World J Gastroenterol; 2015 Jun; 21(23):7181-90. PubMed ID: 26109804
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain.
Rice AS; Smith MT
Clin Pharmacol Ther; 2015 Feb; 97(2):128-30. PubMed ID: 25670516
[TBL] [Abstract][Full Text] [Related]
36. Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon.
Qin HY; Zang KH; Zuo X; Wu XA; Bian ZX
J Med Food; 2019 Jul; 22(7):663-671. PubMed ID: 30920336
[TBL] [Abstract][Full Text] [Related]
37. Effect of water extracts from Cynanchum thesioides (Freyn) K. Schum. on visceral hypersensitivity and gut microbiota profile in maternally separated rats.
Lingpeng P; Jingzhu S; Wei L; Enqi W; Yaqin L
J Ethnopharmacol; 2021 Jan; 264():113352. PubMed ID: 32891821
[TBL] [Abstract][Full Text] [Related]
38. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the angiotensin II type 2 receptor AT
Perryman R; Renziehausen A; Shaye H; Kostagianni AD; Tsiailanis AD; Thorne T; Chatziathanasiadou MV; Sivolapenko GB; El Mubarak MA; Han GW; Zarzycka B; Katritch V; Lebon G; Lo Nigro C; Lattanzio L; Morse SV; Choi JJ; O'Neill K; Kanaki Z; Klinakis A; Crook T; Cherezov V; Tzakos AG; Syed N
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2116289119. PubMed ID: 35917342
[TBL] [Abstract][Full Text] [Related]
40. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
